Avenue therapeutics reports second quarter 2024 financial results and recent corporate highlights

- last patient visit complete in phase 1b/2a clinical trial of aj201 for spinal and bulbar muscular atrophy; topline data anticipated in second half of 2024 –

ATXI Ratings Summary

ATXI Quant Ranking